Financial Ratios Suzhou Dongshan Precision Manufacturing Co., Ltd.
Equities
002384
CNE100000N79
Semiconductors
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 143.55 CNY | +8.83% |
|
+29.85% | +69.58% |
| Apr. 08 | Dongshan Precision Manufacturing's 2025 Profit Soars 22%; Shares Rise 10% | MT |
| Apr. 08 | Dongshan Precision Manufacturing Expects Attributable Profit to Soar Up to 152%; Shares Rise 10% | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.93 | 3.74 | 4.51 | 3.21 | 2.35 | |||||
Return on Total Capital | 5.5 | 5.36 | 6.13 | 4.36 | 3.25 | |||||
Return On Equity % | 14.06 | 13.37 | 15.23 | 11.35 | 5.85 | |||||
Return on Common Equity | 14.09 | 13.47 | 15.31 | 11.38 | 5.87 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 15.95 | 14.09 | 16.14 | 13.91 | 12.7 | |||||
SG&A Margin | 4.15 | 3.48 | 3.63 | 3.83 | 4.17 | |||||
EBITDA Margin % | 13.02 | 12.12 | 14.41 | 12.04 | 10.52 | |||||
EBITA Margin % | 7.81 | 7.15 | 9.03 | 6.61 | 4.74 | |||||
EBIT Margin % | 7.73 | 7.09 | 8.97 | 6.49 | 4.61 | |||||
Income From Continuing Operations Margin % | 5.47 | 5.85 | 7.5 | 5.84 | 2.95 | |||||
Net Income Margin % | 5.45 | 5.86 | 7.5 | 5.84 | 2.95 | |||||
Net Avail. For Common Margin % | 5.45 | 5.86 | 7.5 | 5.84 | 2.95 | |||||
Normalized Net Income Margin | 3.45 | 3.66 | 5.21 | 3.71 | 2.98 | |||||
Levered Free Cash Flow Margin | -4.83 | -3.77 | 3.6 | 1.25 | 2.54 | |||||
Unlevered Free Cash Flow Margin | -3.58 | -3.04 | 4.35 | 2.12 | 3.28 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.81 | 0.84 | 0.8 | 0.79 | 0.81 | |||||
Fixed Assets Turnover | 2.42 | 2.66 | 2.47 | 2.32 | 2.23 | |||||
Receivables Turnover (Average Receivables) | 4 | 3.86 | 3.88 | 4.26 | 4.58 | |||||
Inventory Turnover (Average Inventory) | 4.48 | 4.39 | 4.2 | 4.65 | 5.16 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.13 | 1.15 | 1.23 | 1.26 | 1.18 | |||||
Quick Ratio | 0.77 | 0.76 | 0.85 | 0.86 | 0.79 | |||||
Operating Cash Flow to Current Liabilities | 0.15 | 0.17 | 0.26 | 0.29 | 0.26 | |||||
Days Sales Outstanding (Average Receivables) | 91.55 | 94.59 | 94.05 | 85.62 | 79.92 | |||||
Days Outstanding Inventory (Average Inventory) | 81.63 | 83.05 | 86.95 | 78.49 | 70.95 | |||||
Average Days Payable Outstanding | 107.22 | 115.51 | 114.05 | 106.27 | 111.9 | |||||
Cash Conversion Cycle (Average Days) | 65.96 | 62.12 | 66.95 | 57.85 | 38.98 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 102.54 | 87.22 | 84.29 | 78.07 | 73.66 | |||||
Total Debt / Total Capital | 50.63 | 46.59 | 45.74 | 43.84 | 42.41 | |||||
LT Debt/Equity | 30.1 | 22.2 | 29.53 | 36 | 35.16 | |||||
Long-Term Debt / Total Capital | 14.86 | 11.86 | 16.02 | 20.22 | 20.25 | |||||
Total Liabilities / Total Assets | 64.87 | 61.34 | 59.52 | 59 | 58.96 | |||||
EBIT / Interest Expense | 3.86 | 6.07 | 7.38 | 4.71 | 3.87 | |||||
EBITDA / Interest Expense | 6.51 | 10.61 | 12.12 | 8.9 | 8.99 | |||||
(EBITDA - Capex) / Interest Expense | 2.25 | 2.4 | 3.32 | 1.43 | 0.34 | |||||
Total Debt / EBITDA | 3.69 | 3.25 | 2.97 | 3.44 | 3.53 | |||||
Net Debt / EBITDA | 1.94 | 1.75 | 1.32 | 1.66 | 1.69 | |||||
Total Debt / (EBITDA - Capex) | 10.66 | 14.34 | 10.85 | 21.47 | 93.92 | |||||
Net Debt / (EBITDA - Capex) | 5.59 | 7.73 | 4.8 | 10.38 | 44.97 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 19.28 | 13.17 | -0.67 | 6.56 | 9.27 | |||||
Gross Profit, 1 Yr. Growth % | 21.03 | 3.61 | 13.78 | -8.17 | -0.29 | |||||
EBITDA, 1 Yr. Growth % | 29.6 | 4.69 | 17.13 | -11.58 | -2.95 | |||||
EBITA, 1 Yr. Growth % | 41.61 | 2.52 | 23.82 | -22.92 | -19.19 | |||||
EBIT, 1 Yr. Growth % | 44.3 | 3.75 | 25.59 | -22.74 | -18.09 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 117.84 | 21.06 | 27.21 | -17.02 | -44.78 | |||||
Net Income, 1 Yr. Growth % | 117.76 | 21.72 | 27.12 | -17.05 | -44.74 | |||||
Normalized Net Income, 1 Yr. Growth % | 90.43 | 20.23 | 41.35 | -23.95 | -6.85 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 110.81 | 17.2 | 27.52 | -17.27 | -44.35 | |||||
Accounts Receivable, 1 Yr. Growth % | 29.61 | 7.55 | -9.52 | 4 | -1.02 | |||||
Inventory, 1 Yr. Growth % | 31.18 | 7.94 | -4.43 | 2.08 | -2.24 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.75 | 3.17 | 10.51 | 15.42 | 12.72 | |||||
Total Assets, 1 Yr. Growth % | 18.42 | 1.2 | 6.8 | 8.75 | 3.7 | |||||
Tangible Book Value, 1 Yr. Growth % | 73.51 | 15.01 | 14.9 | 8.54 | 4.47 | |||||
Common Equity, 1 Yr. Growth % | 51.15 | 11.54 | 12.23 | 10.77 | 3.77 | |||||
Cash From Operations, 1 Yr. Growth % | 10.59 | 9.46 | 44.25 | 11.72 | -3.6 | |||||
Capital Expenditures, 1 Yr. Growth % | 118.31 | 27.54 | 10.69 | 2.72 | 9.38 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -188.74 | 20.7 | -194.62 | -62.16 | 165.44 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -151.28 | 50.59 | -242.09 | -47.48 | 88.19 | |||||
Dividend Per Share, 1 Yr. Growth % | 100 | 100.36 | -45.1 | 127.27 | -72 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 19.04 | 16.18 | 6.02 | 2.88 | 7.91 | |||||
Gross Profit, 2 Yr. CAGR % | 20.55 | 10.02 | 8.57 | 2.21 | -4.31 | |||||
EBITDA, 2 Yr. CAGR % | 23.89 | 16.86 | 11.16 | 2.14 | -8.14 | |||||
EBITA, 2 Yr. CAGR % | 18.84 | 21.14 | 13.4 | -1.74 | -22.29 | |||||
EBIT, 2 Yr. CAGR % | 19.18 | 22.37 | 14.15 | -1.57 | -22.54 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 37.67 | 62.39 | 24.1 | 2.76 | -32.31 | |||||
Net Income, 2 Yr. CAGR % | 37.35 | 62.81 | 24.39 | 2.7 | -32.3 | |||||
Normalized Net Income, 2 Yr. CAGR % | 23.87 | 51.25 | 30.36 | 3.6 | -18.26 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 36.2 | 57.39 | 22.25 | 2.72 | -32.14 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.64 | 18.07 | -1.35 | -2.99 | 1.46 | |||||
Inventory, 2 Yr. CAGR % | 22.39 | 18.99 | 1.57 | -1.23 | -0.11 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.23 | 2.96 | 6.77 | 12.94 | 14.07 | |||||
Total Assets, 2 Yr. CAGR % | 9.75 | 9.47 | 3.96 | 8.13 | 6.19 | |||||
Tangible Book Value, 2 Yr. CAGR % | 34.07 | 41.26 | 14.95 | 11.75 | 6.49 | |||||
Common Equity, 2 Yr. CAGR % | 24.62 | 29.84 | 11.88 | 11.56 | 7.21 | |||||
Cash From Operations, 2 Yr. CAGR % | 44.43 | 10.02 | 25.66 | 26.95 | 3.77 | |||||
Capital Expenditures, 2 Yr. CAGR % | -22.37 | 66.86 | 18.82 | 6.63 | 6 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -31.36 | -11.44 | 6.87 | -40.68 | -8.57 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -37.81 | -29.77 | 46.28 | -14.22 | -5.65 | |||||
Dividend Per Share, 2 Yr. CAGR % | 34.84 | 100.18 | 4.88 | 11.7 | -20.23 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 22.22 | 17.05 | 10.27 | 6.2 | 4.97 | |||||
Gross Profit, 3 Yr. CAGR % | 27.5 | 13.28 | 11.26 | 2.68 | 1.37 | |||||
EBITDA, 3 Yr. CAGR % | 40.4 | 17.38 | 17.24 | 3.24 | -0.15 | |||||
EBITA, 3 Yr. CAGR % | 34.64 | 13.54 | 22.55 | 0.09 | -8.89 | |||||
EBIT, 3 Yr. CAGR % | 35.12 | 13.81 | 23.43 | 0.17 | -9.05 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 42.57 | 31.89 | 49.7 | 8.53 | -16.46 | |||||
Net Income, 3 Yr. CAGR % | 42.73 | 31.93 | 49.92 | 8.69 | -16.47 | |||||
Normalized Net Income, 3 Yr. CAGR % | 40.41 | 22.61 | 47.87 | 8.87 | -1.93 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 37.09 | 29.66 | 46.73 | 7.33 | -16.26 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.88 | 7.61 | 8.04 | 0.4 | -2.34 | |||||
Inventory, 3 Yr. CAGR % | 20.98 | 17.37 | 10.61 | 1.74 | -1.57 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 30.28 | 2.54 | 5.41 | 9.58 | 12.87 | |||||
Total Assets, 3 Yr. CAGR % | 19.25 | 6.82 | 8.57 | 5.77 | 6.63 | |||||
Tangible Book Value, 3 Yr. CAGR % | 24.02 | 27.39 | 31.86 | 12.83 | 9.27 | |||||
Common Equity, 3 Yr. CAGR % | 18.91 | 20.1 | 23.68 | 11.56 | 8.9 | |||||
Cash From Operations, 3 Yr. CAGR % | 160.52 | 31.68 | 20.42 | 20.83 | 15.82 | |||||
Capital Expenditures, 3 Yr. CAGR % | -6.93 | -8.4 | 45.53 | 13.19 | 7.54 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -30.17 | -25.33 | -9.46 | -24.83 | -8.04 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -35.62 | -28.08 | -11.18 | 3.48 | 7.64 | |||||
Dividend Per Share, 3 Yr. CAGR % | 35.72 | 53.87 | 30.06 | 35.72 | -29.57 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 47.73 | 30.49 | 15.46 | 11.16 | 9.32 | |||||
Gross Profit, 5 Yr. CAGR % | 50.36 | 34.75 | 18.72 | 8.71 | 4.75 | |||||
EBITDA, 5 Yr. CAGR % | 63.79 | 45.93 | 28.05 | 11.2 | 6.49 | |||||
EBITA, 5 Yr. CAGR % | 83.75 | 52.81 | 25.98 | 7.44 | 2.37 | |||||
EBIT, 5 Yr. CAGR % | 85.25 | 54.37 | 26.31 | 7.39 | 2.42 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 108.05 | 65.66 | 34.87 | 19.36 | 8.99 | |||||
Net Income, 5 Yr. CAGR % | 117.12 | 66.81 | 35.09 | 19.36 | 9.09 | |||||
Normalized Net Income, 5 Yr. CAGR % | 174.06 | 68.57 | 36.28 | 14.62 | 16.62 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 103.31 | 57.27 | 31.02 | 18.13 | 7.78 | |||||
Accounts Receivable, 5 Yr. CAGR % | 33.88 | 19.47 | 4.08 | 3.24 | 5.36 | |||||
Inventory, 5 Yr. CAGR % | 37.19 | 21.32 | 12.8 | 9.54 | 6.19 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 44.51 | 29.33 | 20.31 | 6.58 | 8.79 | |||||
Total Assets, 5 Yr. CAGR % | 40.24 | 20.18 | 12.88 | 7.34 | 7.76 | |||||
Tangible Book Value, 5 Yr. CAGR % | 33.79 | 82.23 | 20.31 | 20.89 | 21.09 | |||||
Common Equity, 5 Yr. CAGR % | 37.22 | 39.77 | 16.05 | 16.61 | 16.84 | |||||
Cash From Operations, 5 Yr. CAGR % | 83.1 | 111.95 | 94.62 | 29.77 | 13.46 | |||||
Capital Expenditures, 5 Yr. CAGR % | 38.31 | 21.41 | 2.62 | -2.66 | 28.2 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 14.88 | -9.62 | -22.21 | -31.89 | -9.42 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 10.01 | -12.39 | -18.27 | -22.83 | -9.26 | |||||
Dividend Per Share, 5 Yr. CAGR % | 71.71 | - | 22.42 | 35.37 | 6.96 |
Select your edition
All financial news and data tailored to specific country editions
















